The Histiocytosis Program offers your child compassionate care from some of the world’s most experienced pediatric oncologists at Dana-Farber Cancer Institute and internationally recognized pediatric subspecialists at Boston Children's Hospital.
While histiocytosis is not a form of cancer, it does share some of the characteristics of cancer and is often treated using some of the same techniques, such as chemotherapy.
Every aspect of your child’s condition is evaluated by a team of specialists with in-depth knowledge of histiocytosis, including pediatric oncologists, dermatologists, orthopedists and radiologists. Other pediatric care providers, including nutritionists, physical and occupational therapists, psychologists and social workers are available for consultation, if needed.
Our treatment approach focuses on family-centered care. From your first visit, you’ll work with a team of professionals who are committed to supporting your family’s needs. We consider you and your child integral parts of the care team. You and your team will work together to create an individualized plan of care for your child.
Children treated in the Histiocytosis Program also benefit from the work of our researchers, who are studying the scientific causes of histiocytosis in order to create new treatment options. We participate in clinical trials sponsored by the Histiocyte Society, offering new therapeutic options to our young patients.
Learn more about treatment and care for children with histiocytosis
We understand that a cancer diagnosis is difficult to cope with. We’re here to help. To schedule a consultation or second opinion for your child, call us at 1-888-733-4662.